Haematopoietic stem cell transplantation (HSCT) is a pivotal therapeutic intervention for diverse haematological disorders, offering the prospect of reconstituting a failing or malignant blood system.

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a ...

The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients: Maryland Monday, December 15, 2025, 15:00 Hrs [IST] A ...

In a newly published review, Professor Xiao-Jun Huang's team at Peking University People's Hospital explore how haploidentical hematopoietic stem cell transplantation (haplo-HSCT), once limited by ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

Phase II trial of 10-day ASTX727 (decitabine/cedazuridine) in combination with venetoclax for relapsed or refractory acute myeloid leukemia. This is an ASCO Meeting ...